Exodus Point Capital Management, LP Guardant Health, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 440,379 shares of GH stock, worth $10.1 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
440,379
Previous 20,286
2070.85%
Holding current value
$10.1 Million
Previous $419,000
2935.32%
% of portfolio
0.09%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$266 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$257 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$139 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$103 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$102 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.34B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...